Order Article Reprints

Ebrahimi R, Barzegari A, Teimuri-Mofrad R, Kordasht HK, Hasanzadeh M, Khoubnasabjafari M, Jouyban-Gharamaleki V, Rad AA, Shadjou N, Rashidi M-R, et al. Selection of Specific Aptamer against Rivaroxaban and Utilization for Label-Free Electrochemical Aptasensing Using Gold Nanoparticles: First Announcement and Application for Clinical Sample Analysis. Biosensors. 2022; 12(10):773. https://doi.org/10.3390/bios12100773

Ebrahimi, Rokhsareh, Abolfazl Barzegari, Reza Teimuri-Mofrad, Houman Kholafazad Kordasht, Mohammad Hasanzadeh, Maryam Khoubnasabjafari, Vahid Jouyban-Gharamaleki, Abbas Afrasiabi Rad, Nasrin Shadjou, Mohammad-Reza Rashidi, and et al. 2022. "Selection of Specific Aptamer against Rivaroxaban and Utilization for Label-Free Electrochemical Aptasensing Using Gold Nanoparticles: First Announcement and Application for Clinical Sample Analysis" Biosensors 12, no. 10: 773. https://doi.org/10.3390/bios12100773

Ebrahimi, R., Barzegari, A., Teimuri-Mofrad, R., Kordasht, H. K., Hasanzadeh, M., Khoubnasabjafari, M., Jouyban-Gharamaleki, V., Rad, A. A., Shadjou, N., Rashidi, M.-R., Afshar Mogaddam, M. R., & Jouyban, A. (2022). Selection of Specific Aptamer against Rivaroxaban and Utilization for Label-Free Electrochemical Aptasensing Using Gold Nanoparticles: First Announcement and Application for Clinical Sample Analysis. Biosensors, 12(10), 773. https://doi.org/10.3390/bios12100773